Classify seizures from their first symptoms, match treatment to the full syndrome, and practice urgent decisions, medication safety and diagnostic uncertainty.
A witness sees stiffening, rhythmic jerking and a slow recovery. That describes a tonic-clonic seizure, but it does not yet tell you where the seizure began. The first task is to reconstruct the event. The next is to decide whether an ongoing emergency, a reversible cause or an enduring tendency to seizures needs treatment.
One convulsion is not automatically epilepsy. Equally, a normal routine EEG does not settle whether an event was epileptic. Use the history, examination, timing, EEG and imaging together.
Name what happened before choosing a drug
A seizure is a transient clinical event caused by abnormal excessive or synchronous neuronal activity. Epilepsy describes an enduring predisposition. It can be diagnosed after two unprovoked or reflex seizures more than 24 hours apart, after one unprovoked or reflex seizure with an estimated recurrence risk of at least 60% over ten years, or when an epilepsy syndrome is established. A seizure during a major acute metabolic disturbance is a different problem from an unprovoked event. Treat the disturbance and assess the underlying brain before deciding on long-term medication. [2]
The 2025 ILAE classification uses focal, generalized, unknown whether focal or generalized, and unclassified categories. Focal seizures arise in networks limited to one hemisphere. Generalized seizures rapidly engage bilateral networks. Consciousness can be preserved or impaired in focal seizures, assessed through awareness and responsiveness. Older records use focal aware, focal impaired awareness, simple partial or complex partial terminology. Translate those terms into the observed behavior instead of discarding the history. [1]
The same final convulsion can have different beginnings
Focal to bilateral
Recurrent rising abdominal sensation, then behavioral arrest, then bilateral stiffening and jerking. The early focal symptoms matter even when the final event looks symmetric.
Generalized
A syndrome with morning bilateral myoclonic jerks and a generalized EEG pattern supports a generalized network disorder.
Unknown whether focal or generalized
The witness arrived after the person fell. Keep the origin uncertain until more evidence is available.
This is a clinical sequence comparison, not an EEG tracing or a map of electrical spread. A missing warning does not prove generalized origin. [1]
Describe the motor event precisely. Tonic means sustained stiffening, clonic means rhythmic repeated jerking, myoclonic means a brief shock-like jerk, and atonic means sudden loss of tone. Tonic-clonic combines phases. Absence is a brief interruption of consciousness, usually with abrupt recovery. Generalized myoclonic seizures do not require loss of consciousness. A drop attack is a description of falling, not proof that the event was atonic. Tonic seizures and other disorders can also cause falls. [1][28]
Ask a witness about the very first symptom, asymmetry, duration and recovery. A smartphone recording obtained safely can help. Tongue injury and incontinence add context but cannot independently classify the seizure or exclude a mimic. An unwitnessed beginning should remain unwitnessed in the diagnosis.
Try it here · Checkpoint 1 of 3
Make your prediction before reading the choices. A first attempt is just a starting point.
Case 1
Show answer and explanations for case 1
A. Generalized tonic-clonic seizure (Why this does not fit)
Bilateral convulsions are compatible with generalized seizures, but the unwitnessed beginning and absent syndrome information prevent establishing that origin.
B. Focal to bilateral tonic-clonic seizure (Why this does not fit)
That sequence requires evidence of a focal beginning; adulthood and the final motor pattern do not supply it.
C. Functional seizure (Why this does not fit)
Neither an unwitnessed onset nor pending EEG establishes a functional diagnosis; positive clinical assessment is needed.
D. Tonic-clonic seizure of unknown whether focal or generalized origin (Best answer)
The motor sequence is described, but nobody observed the beginning and no syndrome evidence establishes its origin.
Takeaway: Describe the observed seizure and preserve uncertainty about its beginning.
Let the beginning and recovery explain the pattern
Temporal seizures may begin with fear, deja vu, an unusual smell or a rising epigastric sensation. Behavioral arrest and oral or manual automatisms can follow, with confusion afterward. An aura is itself a focal seizure symptom, not merely a warning before seizure activity begins. Automatisms are not exclusive to temporal epilepsy; they also occur in absence seizures. [33] The longer event, focal warning and slower recovery favor a temporal origin. Repeated nearly identical spells are more informative than one isolated unusual sensation. [20]
Frontal seizures can be brief, clustered and prominent during sleep, sometimes with vigorous motor behavior. Forced head and eye deviation before bilateral convulsions can help lateralize a focal seizure, but timing and other findings matter. A sensory progression along a limb suggests a focal sensory network, often involving contralateral parietal somatosensory cortex; [35] a motor progression through adjacent body regions is a Jacksonian march.
Brief stereotyped visual phenomena can suggest an occipital origin. Migraine aura typically evolves more gradually. None of these descriptions replaces a full assessment, and a normal scalp recording can miss a small or deep focus. [29][30]
EEG patterns require a clinical partner
Pattern
Useful association
What it cannot prove alone
PatternGeneralized approximately 3 Hz spike-wave during a brief lapse
Useful associationTypical absence
What it cannot prove aloneThat every staring spell is absence
PatternGeneralized spike or polyspike-wave, often 3 to 5.5 Hz
Useful associationJuvenile myoclonic epilepsy with appropriate history
What it cannot prove aloneJME without the characteristic clinical syndrome
PatternSlow generalized spike-wave below 2.5 Hz and fast activity in sleep
Useful associationLennox-Gastaut syndrome
What it cannot prove aloneThe syndrome from a single slow discharge
PatternHypsarrhythmia or another markedly abnormal infant EEG
What it cannot prove aloneThat a less classic EEG makes suspected spasms safe to ignore
PatternFocal epileptiform discharges
Useful associationSupport for focal epilepsy
What it cannot prove aloneThe location of every subsequent seizure
Normal posterior alpha activity in a relaxed awake adult with eyes closed is commonly 8 to 13 Hz; [34] normal background is not a seizure pattern. During a convulsion, muscle artifact may obscure the electrical recording. Read the signal with the synchronized behavior. [18][19][22][4][28]
Todd paresis is transient weakness after a seizure. Stroke can also produce a seizure. New persistent weakness or aphasia warrants immediate stroke assessment; a normal noncontrast CT excludes neither early ischemia nor eligibility for further acute treatment. Do not wait a day to see whether the deficit disappears. [21]
Match treatment to every seizure type the person has
For focal seizures, lamotrigine or levetiracetam are common initial choices in current NICE guidance. Carbamazepine remains useful, but it is not the universal first answer. For generalized tonic-clonic seizures, broad-spectrum choices include lamotrigine, levetiracetam and valproate, with reproductive risks shaping selection. Drug choice also depends on age, kidney and liver function, interactions, comorbidities and local prescribing requirements. A sodium-channel mechanism alone does not tell you which seizure types a drug treats. [3]
These NICE choices are conditional on UK safety requirements. Do not initiate valproate in a person younger than 55 unless two specialists independently agree and document that no other effective, tolerated option exists, or compelling reasons mean the reproductive risks do not apply. For women and girls of childbearing potential, other treatments must be unsuccessful, risks must be discussed and the Pregnancy Prevention Programme applied when appropriate.
Boys and men should receive the MHRA precautionary advice on contraception during treatment and for three months afterward, and specialist review when planning a family. These are UK requirements, not a universal regulatory rule. Topiramate also requires the UK Pregnancy Prevention Programme for women and girls of childbearing potential. [3]
Three childhood patterns that change the prescription
Pure childhood absence epilepsy is a setting for ethosuximide, whose proposed actions include reducing thalamic T-type calcium currents. [36] If absence occurs with generalized tonic-clonic seizures or other seizure types, ethosuximide alone leaves part of the disorder untreated. The childhood absence trial found ethosuximide and valproate more effective than lamotrigine for freedom from treatment failure at 16 or 20 weeks, with fewer attention-related adverse effects on ethosuximide than valproate. That trial was published in the New England Journal of Medicine, and it did not establish zero fetal risk. [22]
In juvenile myoclonic epilepsy, ask specifically about morning jerks that spill a drink or send a toothbrush across the bathroom. Sleep loss can precipitate events. Generalized tonic-clonic seizures may bring the person to care, while myoclonus has gone unreported. Levetiracetam or valproate may fit the syndrome; reproductive circumstances affect the choice. Carbamazepine can aggravate myoclonus or absence, and lamotrigine can occasionally worsen myoclonus. Withdrawal counseling is individualized because relapse is common, not inevitable in every person. [3][18][23]
Clusters of brief flexor or extensor spasms in an infant, especially with developmental slowing, need urgent specialist assessment and sleep EEG. Do not wait for the complete historical West syndrome triad. NICE recommends referral within 24 hours; its first-line approach without tuberous sclerosis is high-dose prednisolone plus vigabatrin unless steroid risk changes the plan. For tuberous sclerosis-associated spasms, vigabatrin is first-line; NICE advises adding high-dose prednisolone if it is ineffective after one week. Hormonal protocols, including ACTH in some settings, require specialist monitoring. This is not routine maintenance treatment for every childhood seizure. [4]
Lennox-Gastaut syndrome combines a developmental course with multiple seizure types, particularly tonic seizures, and characteristic EEG findings. NICE advises considering valproate first-line for Lennox-Gastaut syndrome, subject to its safety restrictions, with lamotrigine and specialist options such as clobazam or rufinamide considered as needed. Treatment can also include dietary therapy and assessment for procedures. Injurious falls may warrant individually fitted protective equipment.
After two adequate, appropriately chosen and tolerated medication schedules fail, refer for a drug-resistant epilepsy evaluation. Resective surgery targets a sufficiently localized seizure-generating region when expected benefit outweighs functional risk. Vagus nerve stimulation aims to reduce seizures through implanted stimulation and may help when resection is unsuitable. Corpus callosotomy interrupts interhemispheric spread and can reduce injurious drop attacks without removing the originating focus.
Referral is for comprehensive assessment, not a commitment to an operation. [28][32][19][4][27]
Try it here · Checkpoint 2 of 3
Make your prediction before reading the choices. A first attempt is just a starting point.
Case 8
Show answer and explanations for case 8
A. Vigabatrin (Best answer)
Tuberous sclerosis-associated infantile spasms are a specific first-line indication, with specialist efficacy and toxicity monitoring.
B. High-dose prednisolone alone (Why this does not fit)
Hormonal treatment is important in infantile spasms, but NICE selects vigabatrin alone initially for TSC-associated spasms.
C. High-dose prednisolone plus vigabatrin from the outset (Why this does not fit)
This is the usual NICE first-line combination for non-TSC spasms without high steroid risk. For TSC, add prednisolone if vigabatrin is ineffective after one week.
D. Levetiracetam (Why this does not fit)
NICE lists this among specialist second-line spasm options after first-line treatment is unsuccessful, not as the initial TSC-specific choice.
Takeaway: An underlying syndrome can change the first treatment even when all events are called seizures.
Mechanisms help explain choices, but do not replace the syndrome. Phenytoin, carbamazepine and lamotrigine act on voltage-sensitive sodium channels. Levetiracetam binds synaptic vesicle protein SV2A. Their different clinical profiles show why a mechanism label alone cannot predict treatment coverage. [15][14][13][24]
Adverse effects that should change an assessment
Drug
Clinical connection
DrugPhenytoin
Clinical connectionGingival overgrowth can complicate chronic use. Nystagmus, ataxia and dysarthria suggest toxicity. Saturable metabolism allows a small dose increase to cause a disproportionate concentration rise. Prenatal exposure can cause malformations and the pattern called fetal hydantoin syndrome. [15]
DrugCarbamazepine
Clinical connectionHyponatremia, serious blood disorders and skin reactions matter. Hepatic enzyme induction can also lower concentrations of interacting medicines. Screen for HLA-B*15:02 before starting in people with ancestry from populations where it occurs; a negative result does not eliminate rash risk. [14]
DrugLamotrigine
Clinical connectionSlow titration reduces serious rash risk. Stop lamotrigine at the first sign of rash unless it is clearly unrelated to the drug; painful rash or mucosal lesions need urgent assessment. Valproate raises lamotrigine exposure. Estrogen-containing contraceptives lower it, and stopping estrogen can raise it again. [13]
DrugLevetiracetam
Clinical connectionIrritability, aggression or other psychiatric symptoms can be medication-related. Kidney function affects dosing. A change to another drug does not guarantee disappearance of behavioral symptoms. [24]
DrugValproate
Clinical connectionConsider hepatotoxicity, pancreatitis, thrombocytopenia and hyperammonemia as well as fetal risk. Valproate is contraindicated in hepatic disease or significant hepatic dysfunction, known POLG-related mitochondrial disease, suspected POLG-related disease in children under two, and urea cycle disorders. In older patients with suspected hereditary mitochondrial disease, the label permits use only after other anticonvulsants fail, with close monitoring. Weight gain and tremor are additional adverse effects. [26]
DrugTopiramate
Clinical connectionWord-finding difficulty, renal stones and metabolic acidosis are related but distinct reasons to reassess therapy. Carbonic anhydrase inhibition contributes to the renal and acid-base effects. Weight loss and fetal risks, including oral clefts, also matter. [25]
Pregnancy planning belongs before conception whenever possible. The 2024 AAN, AES and SMFM guidance favors considering lamotrigine, levetiracetam or oxcarbazepine when appropriate to the syndrome and avoiding valproate when clinically feasible. Uncontrolled convulsions also carry risk. A person who becomes pregnant should contact the prescribing team promptly rather than abruptly stopping medication. Recommend at least 0.4 mg folic acid daily before and during pregnancy; the optimal dose for every antiseizure regimen is not established. [8]
Breastfeeding decisions also require the specific drug and infant. Levetiracetam can reach substantial milk concentrations, yet its use does not automatically require stopping breastfeeding. Observe infant alertness, feeding and weight gain, particularly with multiple maternal sedating drugs, and review maternal dosing after delivery. [12]
Separate rescue treatment from long-term decisions
Convulsive status epilepticus is treated at five minutes of continuous convulsions or with repeated convulsions without recovery. Five minutes is an action threshold, not a claim that irreversible neuronal injury begins at that exact instant. Protect the airway, support breathing and circulation, check glucose, obtain access and give an adequate benzodiazepine promptly. Intravenous lorazepam is appropriate with established access; intramuscular midazolam is useful without it. Community rescue plans may use buccal midazolam or rectal diazepam. Follow the local protocol while looking for the cause. [5][6]
Escalation depends on response
Ongoing convulsions reach the treatment threshold. Stabilize and administer the indicated benzodiazepine.
Convulsions persist despite adequate benzodiazepine treatment. Give an appropriate intravenous second-line antiseizure medicine without unnecessary delay.
Seizures continue. Obtain expert critical care management, airway support and continuous EEG as needed; further medication or anesthetic therapy depends on the situation.
ESETT studied benzodiazepine-refractory convulsive status in patients eligible from age two years. Levetiracetam, fosphenytoin and valproate had similar overall success: about half achieved cessation of clinically apparent seizures plus improved consciousness without additional antiseizure medication at one hour. No overall superiority was demonstrated; this is not proof that the drugs are interchangeable in every patient. Patient factors select among them. The figure is a treatment sequence, not a countdown requiring clinicians to wait. [7][5]
Persistent unresponsiveness after motor activity stops can reflect a postictal state, medication effect, ongoing nonconvulsive seizures or another brain disorder. EEG helps resolve this uncertainty. ACNS consensus advises considering continuous EEG when alertness is not clearly improving within ten minutes, or any impairment persists beyond thirty minutes after clinically evident seizure activity ends. These are assessment prompts, not required waiting periods. [31] Refractory care does not mean that every patient must receive the same anesthetic or an identical burst-suppression target.
For alcohol withdrawal seizures, benzodiazepines treat the withdrawal physiology; oral chlordiazepoxide is not the rescue route for an actively convulsing patient. Give thiamine when indicated, but do not delay correction of hypoglycemia to administer it first. ASAM permits thiamine and glucose in either order or concurrently. [16]
In the neurologically healthy child without prior unprovoked seizures, a simple febrile seizure occurs at age 6 through 60 months, is generalized, lasts less than 15 minutes and occurs once in 24 hours. Evaluate the fever source and recovery. Focality, a prolonged event or recurrence changes that assessment. The 2011 AAP neurodiagnostic guideline states that lumbar puncture is indicated for suspected meningitis; it is an option in selected 6- to 12-month-olds with incomplete or unknown Hib or pneumococcal immunization and in antibiotic-pretreated children.
A well child with a simple event does not routinely need EEG or neuroimaging. Antipyretics address comfort, not active convulsions. A simple febrile seizure does not establish epilepsy; later unprovoked seizure risk is generally low, not zero. [28][11]
After a first unprovoked seizure, discuss recurrence risk, EEG and imaging findings and the person's priorities. Immediate medication reduces early recurrence but does not clearly improve long-term sustained remission. A prior brain insult, epileptiform EEG, relevant imaging abnormality or nocturnal seizure increases concern. [10]
Functional seizures are involuntary events requiring a positive, respectful diagnostic assessment. When feasible, record typical event types with video EEG and interpret the recording with the clinical behavior. A normal routine EEG, eye closure or a prolactin result alone is insufficient. Functional seizures and epilepsy can coexist. Explain the diagnosis, assess coexisting conditions and offer appropriate psychological treatment; antiseizure drugs do not treat functional seizures themselves. [9]
Etiology still matters after classification. In neurocysticercosis, viable, degenerating, calcified and extraparenchymal disease require different plans. Calcified parenchymal lesions do not contain viable parasites for antiparasitic drugs to eradicate. Seizures may still need antiseizure treatment. When antiparasitic therapy is indicated, inflammatory risk and corticosteroid timing belong in a specialist plan. [17]
Try it here · Checkpoint 3 of 3
Make your prediction before reading the choices. A first attempt is just a starting point.
Case 12
Show answer and explanations for case 12
A. An adequate intravenous benzodiazepine such as lorazepam (Best answer)
The convulsive status threshold has been reached and first-line rescue treatment should be prompt.
B. Intravenous levetiracetam (Why this does not fit)
Levetiracetam is a reasonable second-line option if adequate benzodiazepine treatment fails, but no first-line rescue dose has been given here.
C. Intravenous fosphenytoin (Why this does not fit)
This is an established second-line choice, but a promptly administered benzodiazepine is preferred for initial rescue in this setting.
D. Intravenous phenobarbital (Why this does not fit)
Phenobarbital is an effective alternative when preferred benzodiazepines are unavailable, but its slower administration makes it less suitable as the initial choice here.
Takeaway: Five minutes triggers treatment, not another observation period.
A. Generalized myoclonic seizure (Why this does not fit)
Myoclonus is a brief shock-like jerk, not the sustained behavioral arrest, amnesia and post-event language difficulty described.
B. Panic attack (Why this does not fit)
Autonomic abdominal sensations can occur during panic, but the recurring sequence with unresponsiveness, automatisms and post-event language impairment favors a focal seizure.
C. Focal seizure with impaired consciousness, likely temporal (Best answer)
The stereotyped autonomic warning, sustained impaired interaction and postictal language difficulty support a focal temporal network.
D. Typical absence seizure (Why this does not fit)
Absence usually ends abruptly with rapid recovery; the warning and prolonged language difficulty argue against it.
Takeaway: Combine the first symptom with recovery instead of classifying an automatism alone.
A. A previously unrecognized focal frontal epilepsy (Why this does not fit)
The bilateral morning myoclonus with generalized polyspike-wave favors a generalized syndrome over this focal explanation.
B. Carbamazepine can aggravate myoclonus in a generalized epilepsy syndrome (Best answer)
The previously unrecognized myoclonic phenotype changes the interpretation of both diagnosis and drug choice.
C. A class effect showing that lamotrigine must aggravate all of this patient's seizures (Why this does not fit)
Drug effects cannot be inferred from sodium-channel activity alone. Lamotrigine can occasionally worsen myoclonus but also treats some generalized seizure types.
D. New-onset nonepileptic tremor unrelated to the prior events (Why this does not fit)
The jerks predated treatment and accompany an EEG pattern compatible with JME; the supplied pattern is more coherent with aggravated myoclonus.
Takeaway: Revisit the seizure inventory when a maintenance drug aggravates a previously overlooked event type.
A. Levetiracetam achieved the composite treatment outcome in about nine out of ten patients (Why this does not fit)
Overall success was around half, not 90%; success also required improved consciousness without additional medication at one hour.
B. The trial established equal safety for valproate in patients with and without significant hepatic disease (Why this does not fit)
The trial does not override product contraindications. Valproate is contraindicated in hepatic disease or significant hepatic dysfunction.
C. None showed clear overall superiority, so patient factors guide the choice (Best answer)
Among patients eligible from age two with benzodiazepine-refractory convulsive status, about half achieved seizure cessation plus improved consciousness without additional medication at one hour. Absence of demonstrated superiority does not prove equivalence for every patient or safety profile.
D. The adult subgroup established fosphenytoin as the preferred drug on efficacy grounds (Why this does not fit)
The adult results did not demonstrate clear superiority of fosphenytoin over the other study drugs.
Takeaway: Second-line status therapy has several supported options rather than one obligatory drug.
A. Immediate treatment improves the likelihood of sustained remission years later (Why this does not fit)
The guideline found early treatment unlikely to improve long-term sustained remission compared with waiting until recurrence. This differs from its short-term benefit.
B. Immediate and deferred treatment have the same recurrence risk over the next two years (Why this does not fit)
Immediate treatment reduces early recurrence; that benefit belongs in the individual decision even though long-term remission is not improved.
C. Normal MRI places her at the lowest recurrence risk regardless of the other findings (Why this does not fit)
Epileptiform EEG and a nocturnal first seizure are recurrence risk factors despite normal MRI.
D. It can reduce early recurrence; weigh benefits, adverse effects and individual risk (Best answer)
Nocturnal occurrence and epileptiform EEG increase recurrence concern, while immediate treatment mainly improves short-term seizure control.
Takeaway: First-seizure treatment is a risk-benefit decision rather than an automatic yes or no.
A. Continue valproate without medication review and rely on folate to neutralize its fetal risk (Why this does not fit)
Folate is recommended, but it does not make valproate exposure risk-free or replace consideration of effective lower-risk treatment before conception.
B. Arrange preconception specialist review of effective lower-risk options and folate (Best answer)
There is time to balance syndrome control with fetal risk before conception, without abrupt withdrawal.
C. Stop valproate immediately without an alternative (Why this does not fit)
Her documented convulsions during earlier cessation make unsupervised withdrawal particularly unsafe while a suitable alternative regimen is being considered.
D. Postpone medication review until the first prenatal visit (Why this does not fit)
Optimizing an effective regimen before conception allows time to balance seizure control with fetal risks.
Takeaway: Plan a safe regimen before conception whenever possible.
A. Use the standard lamotrigine initiation schedule without accounting for valproate (Why this does not fit)
Valproate raises lamotrigine exposure and requires a lower starting schedule; disregarding that interaction increases serious rash risk.
B. Use a high starting dose and delay further increments for two weeks (Why this does not fit)
A prolonged interval does not compensate for an excessive initial dose. Both initial dose and escalation schedule matter.
C. Escalate according to seizure frequency before considering the interaction (Why this does not fit)
Seizure control does not justify exceeding the valproate-adjusted titration schedule. The painful rash with mucosal involvement now requires urgent assessment and drug discontinuation unless clearly unrelated.
D. Use the valproate-adjusted low starting dose and slow lamotrigine titration (Best answer)
Valproate inhibits lamotrigine elimination. Excess initial dosing and rapid escalation increase serious rash risk. Stop at the first sign of rash unless clearly unrelated, and urgently assess the current painful rash and oral erosions.
Takeaway: A serious rash is a clinical emergency, and lamotrigine titration depends on interacting drugs.
A. CYP2D6 metabolizer testing (Why this does not fit)
This is not the HLA marker implicated in carbamazepine-associated SJS/TEN by the cited product warning.
B. HLA-B*58:01 testing (Why this does not fit)
The carbamazepine warning for this population concerns HLA-B*15:02; this different allele does not replace that screening.
C. HLA-B*15:02 testing (Best answer)
The label recommends screening before initiation in genetically at-risk populations. A positive result generally argues against carbamazepine unless benefit clearly outweighs risk; a negative result does not eliminate all serious rash risk.
D. TPMT activity testing (Why this does not fit)
This does not assess the HLA-B*15:02 association underlying the carbamazepine SJS/TEN warning.
Takeaway: Use pharmacogenetics for the adverse reaction it predicts, without treating a negative result as a guarantee.
A. Stop breastfeeding permanently before assessing the infant (Why this does not fit)
Some infants can become sedated, but levetiracetam exposure does not impose a universal permanent breastfeeding prohibition. Assess the symptomatic infant promptly.
B. Promptly assess the infant and review drug exposure, feeding and maternal dosing (Best answer)
Milk concentrations can be substantial and sedation is reported. Prompt assessment must also consider other causes of neonatal illness rather than assuming medication exposure explains poor feeding. Review the feeding plan and maternal dosing without abrupt unsupervised cessation.
C. Observe feeding at home because infant serum concentrations are often low (Why this does not fit)
Low concentrations in many infants do not exclude clinically important effects in this infant or other neonatal illness. Sleepiness with poor feeding requires prompt assessment.
D. Reduce maternal levetiracetam without reviewing seizure control or examining the infant (Why this does not fit)
Changing maternal treatment without assessment may destabilize seizure control and miss another cause of the infant symptoms.
Takeaway: Compatibility with breastfeeding still includes monitoring the individual infant.
A. Stop epilepsy treatment because functional seizures were documented (Why this does not fit)
Confirmation of one event type does not erase the separately demonstrated epileptic seizures.
B. Escalate antiseizure drugs until the functional events stop (Why this does not fit)
Antiseizure drugs treat the separately confirmed epilepsy; increasing them solely for the functional event type adds exposure without treating that mechanism.
C. Refer for psychological care while deferring management of the documented focal seizures (Why this does not fit)
Functional seizure care is needed, but it does not replace treatment of independently established coexisting epilepsy.
D. Treat the epilepsy appropriately and offer specific care for the functional seizures (Best answer)
Coexistence requires explaining both diagnoses and matching treatment to each event type.
Takeaway: One confirmed diagnosis does not exclude a second event type.
A. Withhold antiseizure treatment because the parasites are no longer viable (Why this does not fit)
Seizure risk can persist around calcified lesions despite the absence of living parasites.
B. Treat each recurrent seizure with corticosteroids as the primary long-term strategy (Why this does not fit)
Seizures need appropriate antiseizure management. The guideline does not recommend routine corticosteroids for isolated calcified parenchymal disease, even with perilesional edema.
C. Treat the seizures as indicated without antiparasitic therapy for the calcified lesions (Best answer)
Calcified lesions do not contain viable parasites for antiparasitic treatment, though they can remain associated with seizures.
D. Add albendazole and corticosteroids for residual viable infection (Why this does not fit)
The imaging specifies calcified lesions without viable cysts. Antiparasitic treatment cannot eradicate parasites that are no longer viable.
Takeaway: Viability and anatomical compartment determine the neurocysticercosis treatment plan.
A. Proceed directly to resection on the MRI finding alone (Why this does not fit)
Concordant imaging is helpful but does not replace the comprehensive presurgical assessment of seizure origin and functional risk.
B. Refer for full drug-resistant epilepsy assessment, including surgical candidacy (Best answer)
Failure of two appropriate regimens meets the standard threshold for considering specialized options; concordance may inform evaluation.
C. Defer specialist referral until several additional medication combinations have failed (Why this does not fit)
Failure of two adequate, tolerated, appropriately chosen schedules establishes drug resistance and supports referral now, rather than an arbitrary additional-drug requirement.
D. Select corpus callosotomy as the default procedure for the temporal lesion (Why this does not fit)
Callosotomy interrupts spread and can help selected injurious drop attacks; a focal temporal lesion calls for evaluation of localization and resective options instead of a default disconnection procedure.
Takeaway: A referral is an evaluation of options, not an automatic commitment to a procedure.
A. Right hemispheric motor networks, with frontal involvement plausible (Best answer)
Early forced contralateral version together with left-sided motor activity supports a right-sided focal beginning.
B. Left frontal motor networks (Why this does not fit)
The consistently left-sided version followed by left arm clonic activity favors contralateral right hemispheric motor network involvement.
C. Generalized origin without a focal beginning (Why this does not fit)
A final bilateral convulsion does not override a clearly recorded, recurring lateralized early sequence.
D. Right occipital cortex established as the seizure origin (Why this does not fit)
Occipital seizures may spread into motor networks, but the supplied motor sequence without an early visual phenomenon does not establish occipital onset.
Takeaway: The earliest reliably observed lateralized signs carry more localizing value than the final convulsion.
